Beginning January 1, 2021, a federal law called the Every Prescription Conveyed Securely Act takes effect requiring that prescriptions for controlled substances covered under Medicare be prescribed electronically.
The DEA has issued a warning concerning an extortion scam involving calls from someone purporting to be a DEA agent attempting to extort money.
Vaccination with mRNA-1273, Moderna’s coronavirus disease 2019 (COVID-19) vaccine candidate, led to robust immune responses and protection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in nonhuman primates.
Sputum sampling was found to be a valuable method for diagnosing and monitoring patients with coronavirus disease 2019 (COVID-19), according to a recent systematic review and meta-analysis published in EBioMedicine.
Pfizer and BioNTech have selected a coronavirus disease 2019 (COVID-19) vaccine candidate and have initiated their phase 2/3 safety and efficacy trial.
Clinicians are more likely to counsel younger and female patients on reproductive risks before initiating chemotherapy, despite available ASCO guidelines.
Previously conducted retrospective studies may have underestimated the incidence of hydroxyurea-related skin toxicity in patients with MPNs.
The BLA submission includes data from a phase 3 study comparing inolimomab to antithymocyte globulin in 100 adults with steroid-refractory aGVHD.
The trial, which is the first to be implemented under Operation Warp Speed, is expected to enroll around 30,000 adults and will be conducted at multiple clinical research sites across the US.
Monitoring hematological and coagulation parameters with rapid blood tests may aid clinicians in the prognosis and severity assessment of COVID-19.
Researchers report a case of intravascular hemolysis and methemoglobinemia in man with T2D and hypertension who tested positive for SARS-CoV-2 pneumonitis.
The US Department of Health and Human Services and the Department of Defense have agreed to receive 100 million doses of BNT162, a vaccine for SARS-CoV-2, once the manufacturers obtains approval or emergency use authorization (EUA) from the Food and Drug Administration.
Communication breakdowns associated with a loss of hearing can potentially impact older patients’ adherence to treatment plans.
For patients receiving HLA-matched sibling donor transplantation, antithymocyte globulin can reduce the incidence of acute graft-vs-host-disease.
Researchers examined causes of avoidable chemotherapy delays as a means of improving the quality of care for outpatients receiving chemotherapy.
Putting information in the cloud can be a good move for a physician’s practice — but only if done well.
Due to the COVID-19 pandemic, patterns of blood transfusion demands are not certain; therefore, institutions should plan for a reduction in donations.
COVID-19 has brought unprecedented stress to society at large and perhaps most of all to frontline healthcare teams in a variety of settings. We spoke to an expert about teamwork during such trying times.
In addition to being common yet serious diseases, both cancer and fibromyalgia bring a high burden of physical pain and negative effects on mental health.
The Consistent Testing Terminology Working Group selected plain language terminology that can be used when communicating with cancer patients about genetic testing.
Nurse-led protocol maintains hematology-oncology patient safety with VSM extended to once every 8 hours.
Two recent papers are encouraging cancer center executives to rethink how they position their services to potential patients.
ChemoCentryx, Inc has submitted a NDA to the Food and Drug Administration (FDA) for acavopan in the treatment of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis.
Matched cohort study showed risk greatest for those with primary myelofibrosis, but still high for those with polycythemia vera and essential thrombocythemia.
An analysis of more than 300 patients with hematologic cancer found that cognitive impairment had a negative effect on outcomes, whereas age and IADLs did not.
Long-term survivors of childhood cancers with exercise intolerance may have emotional distress, less social role achievement, and worse HRQOL.
There are up to 80 ADCs in clinical development with close to 600 ongoing trials.
Prospective trials regarding sedentary lifestyles and all cause mortality using measurements more objective than self-reported activity are currently lacking.
The association between functional impairment and symptom burden was shown to be predictive of outcomes for older patients with advanced cancer.
Physicians should frame treatment options by their “harms and benefits,” not by their “risks and benefits.”
Patients with cancer are more susceptible to infection with SARS-CoV-2, and patients receiving active anticancer treatment have a poorer prognosis.
Upon starting methotrexate treatment, LDH and albumin levels may be signals for AKIs in patients with hematologic malignancies.
Givosiran improved the rate of porphyria attacks in patients with acute intermittent porphyria compared with placebo.
Several factors were found to affect whether patients with cancer received a palliative care consultation at a tertiary care center.
For patients with GVHD, ruxolitinib improves efficacy outcomes compared with 9 other commonly used options.
The first set of guidelines for providing oncology pharmacy services to cancer patients during the COVID-19 pandemic was recently published.
Costs of care for patients with cancer was found to vary based on stage and site of disease.
The American Society of Clinical Oncology published new clinical guidelines on the management of cachexia in adults with advanced cancer.
A review of practices prior to a change in nivolumab dosing demonstrated that bodyweight dosing resulted in a 6.1% rate of wastage at a significant cost compared with a fixed dose of 240 mg per dose.
Although emapalumab is an effective treatment for primary hemophagocytic lymphohistiocytosis (HLH), further research is needed for secondary forms of HLH.
For patients with cancer, COVID-19-related death may be driven by age, male gender, and comorbitities.
The FDA has approved Nyvepria™ (pegfilgrastim-apgf; Pfizer), a biosimilar to Neulasta (pegfilgrastim; Amgen).
The HLA-DPB1 mismatch expression level and number of mismatches was associated with GVHD after unrelated donor HCT.
Telemedicine and coordination of care by an ONN helped provide access to fertility preservation services from a distant tertiary care center for women with cancer.
A recently published report describes the case of a 61-year-old male patient who experienced antacid-induced hypercalcemia and highlights the importance of performing thorough medication reconciliation.
The analysis included results from 2 tests that have received EUA: the SARS-CoV-2 ELISA test (Euroimmun) and the COVID-19 IgG/IgM Rapid Test Cassette (Healgen).
Acalabrutinib, a Bruton tyrosine kinase (BTK) inhibitor, appears to reduce respiratory distress as well as the hyperinflammatory immune response associated with coronavirus disease 2019.
Deferiprone effectively induces control of iron overload in pediatric patients with transfusion-dependent hemoglobinopathies.
A EULAR task force developed recommendations for the diagnosis and management of rheumatic immune-related adverse events due to cancer immunotherapy.
A review of techniques oncology nurses can use to help themselves cope with their feelings as they navigate through the effects of the COVID-19 pandemic on their practice, their patients, and themselves.
The FDA previously granted Fast Track and Orphan Drug designations to mepolizumab for the treatment of HES.